Lennar Other Income (Expense) increased by 107.7% to $8.15M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 74.3%, from $31.67M to $8.15M. Over 2 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -41.3% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '21 | Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.21M | $45.21M | $45.21M | -$7.56M | -$19.30M | $23.32M | -$9.96M | $44.15M | $65.37M | $68.17M | $23.33M | $68.99M | $31.67M | $30.76M | -$18.96M | -$105.82M | $8.15M |
| QoQ Change | — | +0.0% | +0.0% | -116.7% | -155.2% | +220.9% | -142.7% | +543.3% | +48.1% | +4.3% | -65.8% | +195.7% | -54.1% | -2.9% | -161.6% | -458.3% | +107.7% |
| YoY Change | — | — | — | -116.7% | -142.7% | — | -31.7% | +328.8% | +180.3% | +784.5% | -47.2% | — | -51.6% | -54.9% | -181.2% | -253.4% | -74.3% |
| Segment | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Lennar Other | -$16.33M | -$16.33M | $11.31M | $11.31M | $11.31M | $11.31M | -$8.12M | $1.14M |
| Total | $44.15M | — | $65.37M | $68.17M | $23.33M | $68.99M | $31.67M | $8.15M |
Financial Services is derived from annual filings.